Literature DB >> 32476865

Connective tissue disease associated interstitial pneumonia: a challenge for both rheumatologists and pulmonologists.

Sarah Geerts1, Wim Wuyts2, Ellen De Langhe3, Jan Lenaerts3, Jonas Yserbyt2.   

Abstract

Interstitial lung disease (ILD) can be either idiopathic, the result of exposure or may be associated with extrapulmonary diseases. Among the latter, connective tissue diseases (CTDs) make up the largest part. The identification, follow-up and treatment of CTD-associated ILD (CTD-ILD) are a challenge for every physician as ILD can occur before, during and after the diagnosis of CTD. Early detection of pulmonary involvement is an essential task for the treating rheumatologist and recognition of the underlying CTD can pose a challenge for the treating pulmonologist. Multidisciplinary engagement towards the patient is therefore indispensable for optimal clinical care. (Sarcoidosis Vasc Diffuse Lung Dis 2017; 34: 326-335). Copyright:
© 2017.

Entities:  

Keywords:  collagen vascular disease; connective tissue disease; diagnosis; evaluation; interstitial lung disease; pulmonary fibrosis; treatment

Year:  2017        PMID: 32476865      PMCID: PMC7170069          DOI: 10.36141/svdld.v34i4.5894

Source DB:  PubMed          Journal:  Sarcoidosis Vasc Diffuse Lung Dis        ISSN: 1124-0490            Impact factor:   0.670


  62 in total

Review 1.  Pulmonary complications of connective tissue diseases.

Authors:  Felix Woodhead; Athol U Wells; Sujal R Desai
Journal:  Clin Chest Med       Date:  2008-03       Impact factor: 2.878

Review 2.  Current approach to connective tissue disease-associated interstitial lung disease.

Authors:  Joshua J Solomon; Sandra Chartrand; Aryeh Fischer
Journal:  Curr Opin Pulm Med       Date:  2014-09       Impact factor: 3.155

3.  Detection of Rheumatoid Arthritis-Interstitial Lung Disease Is Enhanced by Serum Biomarkers.

Authors:  Tracy J Doyle; Avignat S Patel; Hiroto Hatabu; Mizuki Nishino; Guodong Wu; Juan C Osorio; Maria F Golzarri; Andres Traslosheros; Sarah G Chu; Michelle L Frits; Christine K Iannaccone; Diane Koontz; Carl Fuhrman; Michael E Weinblatt; Souheil Y El-Chemaly; George R Washko; Gary M Hunninghake; Augustine M K Choi; Paul F Dellaripa; Chester V Oddis; Nancy A Shadick; Dana P Ascherman; Ivan O Rosas
Journal:  Am J Respir Crit Care Med       Date:  2015-06-15       Impact factor: 21.405

4.  Comparison of disease progression and mortality of connective tissue disease-related interstitial lung disease and idiopathic interstitial pneumonia.

Authors:  S V Kocheril; B E Appleton; E C Somers; E A Kazerooni; K R Flaherty; F J Martinez; B H Gross; L J Crofford
Journal:  Arthritis Rheum       Date:  2005-08-15

Review 5.  The role of bronchoalveolar lavage in interstitial lung disease.

Authors:  Keith C Meyer
Journal:  Clin Chest Med       Date:  2004-12       Impact factor: 2.878

6.  Detection of inflammatory lesions by f-18 fluorodeoxyglucose positron emission tomography in patients with polymyositis and dermatomyositis.

Authors:  Takayoshi Owada; Reika Maezawa; Kazuhiro Kurasawa; Harutsugu Okada; Satoko Arai; Takeshi Fukuda
Journal:  J Rheumatol       Date:  2012-07-01       Impact factor: 4.666

Review 7.  Interstitial lung disease in connective tissue disease--mechanisms and management.

Authors:  Athol U Wells; Christopher P Denton
Journal:  Nat Rev Rheumatol       Date:  2014-09-30       Impact factor: 20.543

Review 8.  Connective tissue disease-associated lung disease.

Authors:  Amy L Olson; Kevin K Brown; Aryeh Fischer
Journal:  Immunol Allergy Clin North Am       Date:  2012-11       Impact factor: 3.479

Review 9.  Management of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary Fibrosis.

Authors:  Shunsuke Mori
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-09-08

10.  First Data on Efficacy and Safety of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis and Forced Vital Capacity of ≤50 % of Predicted Value.

Authors:  Wim A Wuyts; Martin Kolb; Susanne Stowasser; Wibke Stansen; John T Huggins; Ganesh Raghu
Journal:  Lung       Date:  2016-07-04       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.